Skip to Content

Join the 'Brinzolamide' group to help and get support from people like you.

Brinzolamide News

Generic Eye Drops for Seniors Could Save Millions of Dollars a Year

Posted 28 Jul 2017 by Drugs.com

FRIDAY, July 28, 2017 – Prescribing generic drugs for seniors' eye problems could save the U.S. government hundreds of millions of dollars a year, a new study suggests. Conditions like glaucoma and dry eye that require daily eye drops are common in old age. University of Michigan researchers report that eye doctors caring for seniors prescribe brand-name medications in more than three-quarters of cases, compared to one-third of cases among nearly all other specialties. "Lawmakers are currently looking for ways to reduce federal spending for health care, and policies that favor generics over brand medications or allow Medicare to negotiate drug prices may lead to cost savings," said study senior author Lindsey De Lott, of the university's Kellogg Eye Center. "Using a brand medication for a single patient may not seem like a big deal, but ultimately, these higher costs are paid by all of ... Read more

Related support groups: Eye Conditions, Glaucoma, Eye Dryness/Redness, Cataract, Glaucoma (Open Angle), Lumigan, Latanoprost, Xalatan, Travatan, Combigan, Alphagan, Travatan Z, Systane, Azopt, Cosopt, Dorzolamide, Refresh, Soothe, Dry Eye Disease, Brimonidine

Alcon Announces FDA Approval of Simbrinza Suspension, a New Beta Blocker-Free, Fixed-Combination Therapy for Glaucoma Patients

Posted 23 Apr 2013 by Drugs.com

Basel, April 19, 2013 – Alcon, the global leader in eye care and a division of Novartis, announces US FDA approval for Simbrinza Suspension, indicated for the reduction of elevated intraocular pressure (IOP) in patients with primary open-angle glaucoma or ocular hypertension.4 Elevated IOP is the only modifiable risk factor for glaucoma. Glaucoma is a group of eye diseases that lead to progressive damage of the optic nerve5 and can result in gradual, irreversible loss of vision, and eventually blindness, if left untreated.6 Glaucoma affects more than 2.2 million Americans7 and is the second-leading cause of preventable blindness worldwide.8 Simbrinza is a fixed-dose combination medication that offers a wide range of treatment possibilities due to its strong efficacy and ability to decrease elevated IOP by 21- 35%.1,2,3 In addition, it is the only available, fixed-dose combination ... Read more

Related support groups: Glaucoma, Glaucoma (Open Angle), Intraocular Hypertension, Brimonidine, Brinzolamide

Ask a Question

Further Information

Related Condition Support Groups

Glaucoma (Open Angle), Intraocular Hypertension

Related Drug Support Groups

Azopt

Brinzolamide Patient Information at Drugs.com